Safety and Immunogenicity of pDNA Vaccines Expressing HIV M Group p24^Gag Conserved Elements and/or p55^Gag, Administered With IL-12 pDNA
Clinical trial NCT03181789 · COMPLETED
Trial details
- NCT number
- NCT03181789
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-18
- Primary completion
- 2019-10-25
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.